about
Prediction of graft-versus-host disease in humans by donor gene-expression profilingElafin is a biomarker of graft-versus-host disease of the skinCCL8 is a potential molecular candidate for the diagnosis of graft-versus-host diseaseModern approaches to HLA-haploidentical blood or marrow transplantationImproved accuracy of acute graft-versus-host disease staging among multiple centersSystemic causes of cholestasisNew insight for the diagnosis of gastrointestinal acute graft-versus-host diseaseCorrelation and Agreement of Handheld Spirometry with Laboratory Spirometry in Allogeneic Hematopoietic Cell Transplant RecipientsHHV-6 reactivation and its effect on delirium and cognitive functioning in hematopoietic cell transplantation recipientsImpact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation.Low CD34 dose is associated with poor survival after reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndromeDoes total body irradiation conditioning improve outcomes of myeloablative human leukocyte antigen-identical sibling transplantations for chronic lymphocytic leukemia?Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission.Who is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer?Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemiaReduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes.Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysisLong-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting.Fludarabine and 2-Gy TBI is superior to 2 Gy TBI as conditioning for HLA-matched related hematopoietic cell transplantation: a phase III randomized trialEffect of HLA-matching recipients to donor noninherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancyDonor lymphocyte infusion for relapsed hematological malignancies after allogeneic hematopoietic cell transplantation: prognostic relevance of the initial CD3+ T cell dose.International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium.Clinical significance of platelet count at day +60 after allogeneic peripheral blood stem cell transplantation.Posttransplant autoimmune hemolytic anemia and other autoimmune cytopenias are increased in very young infants undergoing unrelated donor umbilical cord blood transplantation.A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens.Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative studyDynamic International Prognostic Scoring System scores, pre-transplant therapy and chronic graft-versus-host disease determine outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis.Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trialA Prospective Study of Alemtuzumab as a Second-Line Agent for Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Transplantation.Association of IL-10 and IL-10Rbeta gene polymorphisms with graft-versus-host disease after haematopoietic stem cell transplantation from an HLA-identical sibling donorA risk factor analysis of outcomes after unrelated cord blood transplantation for children with Wiskott-Aldrich syndromeSequential monitoring of lymphocyte subsets and of T-and-B cell neogenesis indexes to identify time-varying immunologic profiles in relation to graft-versus-host disease and relapse after allogeneic stem cell transplantationHematopoietic stem cell transplantation: a primer for the primary care physicianAllogeneic transplantation for primary myelofibrosis with BM, peripheral blood or umbilical cord blood: an analysis of the JSHCTAllogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome.HLA-haploidentical donor lymphocyte infusions for patients with relapsed hematologic malignancies after related HLA-haploidentical bone marrow transplantation.A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantationDonor and recipient CMV serostatus and outcome of pediatric allogeneic HSCT for acute leukemia in the era of CMV-preemptive therapy.Outcomes of related donor HLA-identical or HLA-haploidentical allogeneic blood or marrow transplantation for peripheral T cell lymphomaEndothelial microparticles delivering microRNA-155 into T lymphocytes are involved in the initiation of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
P2860
Q21092376-D82AF3B4-D032-4215-92C3-25E77F95195BQ24622918-C4CB9C53-275F-4BD7-A005-0CC527577868Q24644566-CCF000BA-9183-44C1-B623-EC76A183E2E3Q26797506-26C31F38-F988-4675-B90D-F91E07B6655DQ26999931-E97E4FE6-0BA8-4C88-80FD-EDB89BBC0BD9Q27008041-73E8273C-D8CE-4C2D-A1E9-C006A9BED42EQ28238251-04BAA938-1C94-444F-A21B-4CD2B0FC4D2AQ28391717-8E90F958-A816-48B0-9CF5-268257359E39Q28743914-D1D76A72-2975-44C3-8088-C07E01E8A751Q30274960-3C1ADB33-7820-4D81-AB36-485C2E654D40Q30371042-0491BA37-D9DA-4B94-8564-00067BEC4975Q30407633-175FFC58-7462-4A38-8498-66BC4751055CQ30408294-A53568C7-715D-4C21-8B25-149282298F5BQ30414156-356C2C73-E165-481B-811F-ECAFCE1AB391Q30415126-7BF186F1-73BD-460B-B4C9-90B0F9B5ACBCQ30418861-FB0CD995-BA39-4DD9-BA8D-53457185C9A2Q30424777-5190F612-0C5D-4153-BBC3-7B5E674EA66DQ30486842-224025D8-C72C-4C11-9F8B-1D9BF23851FDQ30543777-1E1ADB7D-671F-4469-A952-2CDBD63B1E90Q30557220-BDABB97E-D4E4-4602-82CC-C1727F956A4FQ30558271-B8678990-6C48-49CD-9760-F93C0ADF53D6Q30994673-5D194509-94CC-4FB3-B10D-165D50DCEB54Q33370269-DD44DE6A-02FA-4F5B-85E7-B432ECEFA6A9Q33381227-04F97844-ACB7-4AC4-A7B2-943CE306C088Q33387336-F599D5BF-BA88-48D1-B5EB-366378B284F6Q33395718-73583A8B-7175-4033-B73D-2FE4184099B8Q33400683-B444E110-A3E0-47BE-B5FE-79D120AADE28Q33411822-41084499-BBDE-4741-B049-485B7A2742B2Q33435568-837F9E25-A160-40CF-827F-03E9E7866A5DQ33437907-37ABD634-04D1-4918-AB3E-2043E0965E0EQ33439801-B8425C56-7128-4A86-ACEA-5C6DE889A753Q33554385-7D1788C7-A0D7-44C1-8AB0-64A4742B29D1Q33555232-873E73B9-B3FE-478F-834A-A9EDB2AD0D8EQ33556843-52A9B378-B3C0-4B6D-9C6A-AE3575492E3BQ33560410-0A7764A3-4AA2-40AE-A7E8-B2E51E358E7EQ33566388-0EE0914B-0285-4B41-B8DE-811E316A4646Q33573529-1DA6233F-AEC0-4937-9F9C-C36041AF16CAQ33576882-80478EF4-4522-4F5E-824E-0324024F6753Q33608520-F11434E9-C4D1-4B3C-8F58-3BE159B0FEFEQ33618681-2AA65804-28DE-42BF-9834-2DD417CD329D
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
1994 Consensus Conference on Acute GVHD Grading
@en
1994 Consensus Conference on Acute GVHD Grading
@nl
type
label
1994 Consensus Conference on Acute GVHD Grading
@en
1994 Consensus Conference on Acute GVHD Grading
@nl
prefLabel
1994 Consensus Conference on Acute GVHD Grading
@en
1994 Consensus Conference on Acute GVHD Grading
@nl
P2093
P1476
1994 Consensus Conference on Acute GVHD Grading
@en
P2093
P304
P407
P577
1995-06-01T00:00:00Z